{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:56:48Z","timestamp":1776070608990,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1124\/jpet.105.091231","type":"journal-article","created":{"date-parts":[[2005,9,19]],"date-time":"2005-09-19T18:28:09Z","timestamp":1127154489000},"page":"397-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Relationship between in Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine Analogs"],"prefix":"10.1016","volume":"315","author":[{"given":"Rajeev I.","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Kopajtic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy H.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.091231_bib1","doi-asserted-by":"crossref","unstructured":"Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, and Newman AH (1997) Novel N-substituted 3\u03b1-[bis(4\u2032-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40: 4329-4339.","DOI":"10.1021\/jm970525a"},{"key":"10.1124\/jpet.105.091231_bib2","doi-asserted-by":"crossref","unstructured":"Baumann MH, Char GU, De Costa BR, Rice KC, and Rothman RB (1994) GBR 12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271: 1216-1222.","DOI":"10.1016\/S0022-3565(25)24002-2"},{"key":"10.1124\/jpet.105.091231_bib3","doi-asserted-by":"crossref","unstructured":"Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251: 150-155.","DOI":"10.1016\/S0022-3565(25)20689-9"},{"key":"10.1124\/jpet.105.091231_bib4","doi-asserted-by":"crossref","unstructured":"Carroll FI, Lewin AH, and Mascarella SW (1997) Dopamine-transporter uptake blockers, in Neurotransmitter Transporters (Reith MEA ed) pp 381-432, Humana Press, Totowa, NJ.","DOI":"10.1385\/1-59259-158-2:381"},{"key":"10.1124\/jpet.105.091231_bib5","doi-asserted-by":"crossref","unstructured":"Chen N, Zhen J, and Reith ME (2004) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. J Neurochem 89: 853-864.","DOI":"10.1111\/j.1471-4159.2004.02386.x"},{"key":"10.1124\/jpet.105.091231_bib6","doi-asserted-by":"crossref","unstructured":"Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, and Kuhar MJ (1992) Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. J Pharmacol Exp Ther 260: 1174-1179.","DOI":"10.1016\/S0022-3565(25)11425-0"},{"key":"10.1124\/jpet.105.091231_bib7","doi-asserted-by":"crossref","unstructured":"Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25: 1889-1893.","DOI":"10.1523\/JNEUROSCI.4778-04.2005"},{"key":"10.1124\/jpet.105.091231_bib8","doi-asserted-by":"crossref","unstructured":"Fowler JS, Volkow ND, Logan J, Gatley SJ, Pappas N, King P, Ding YS, and Wang GJ (1998) Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations. Synapse 28: 111-116.","DOI":"10.1002\/(SICI)1098-2396(199802)28:2<111::AID-SYN1>3.0.CO;2-E"},{"key":"10.1124\/jpet.105.091231_bib9","doi-asserted-by":"crossref","unstructured":"Gatley SJ, Volkow ND, Chen R, Fowler JS, Carroll FI, and Kuhar MJ (1996) Displacement of RTI-55 from the dopamine transporter by cocaine: implications for pharmacotherapy of stimulant abuse and in vivo imaging. Eur J Pharmacol 296: 145-151.","DOI":"10.1016\/0014-2999(95)00698-2"},{"key":"10.1124\/jpet.105.091231_bib10","doi-asserted-by":"crossref","unstructured":"Gatley SJ, Volkow ND, Gifford AN, Ding YS, Logan J, and Wang GJ (1997) Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine. Biochem Pharmacol 53: 43-52.","DOI":"10.1016\/S0006-2952(96)00655-7"},{"key":"10.1124\/jpet.105.091231_bib11","doi-asserted-by":"crossref","unstructured":"Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding YS, and Logan J (1999) Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146: 93-100.","DOI":"10.1007\/s002130051093"},{"key":"10.1124\/jpet.105.091231_bib12","doi-asserted-by":"crossref","unstructured":"Heikkila RE, Orlansky H, and Cohen G (1975) Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847-852.","DOI":"10.1016\/0006-2952(75)90152-5"},{"key":"10.1124\/jpet.105.091231_bib13","doi-asserted-by":"crossref","unstructured":"Javitch JA, Blaustein RO, and Snyder SH (1984) [3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 26: 35-44.","DOI":"10.1016\/S0026-895X(25)14974-2"},{"key":"10.1124\/jpet.105.091231_bib14","doi-asserted-by":"crossref","unstructured":"Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3\u03b1-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288: 302-315.","DOI":"10.1016\/S0022-3565(24)37956-X"},{"key":"10.1124\/jpet.105.091231_bib15","doi-asserted-by":"crossref","unstructured":"Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309: 650-660.","DOI":"10.1124\/jpet.103.060525"},{"key":"10.1124\/jpet.105.091231_bib16","doi-asserted-by":"crossref","unstructured":"Kennedy LT and Hanbauer I (1983) Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem 41: 172-178.","DOI":"10.1111\/j.1471-4159.1983.tb13666.x"},{"key":"10.1124\/jpet.105.091231_bib17","doi-asserted-by":"crossref","unstructured":"Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14: 299-302.","DOI":"10.1016\/0166-2236(91)90141-G"},{"key":"10.1124\/jpet.105.091231_bib18","doi-asserted-by":"crossref","unstructured":"Lever JR, Scheffel U, Stathis M, Seltzman HH, Wyrick CD, Abraham P, Parham K, Thomas BF, Boja JW, Kuhar MJ, et al. (1996) Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3\u03b2-(4-[125I]iodophenyl) tropan-2\u03b2-carboxylic acid isopropyl ester ([125I]RTI-121). Nucl Med Biol 23: 277-284.","DOI":"10.1016\/0969-8051(95)02074-8"},{"key":"10.1124\/jpet.105.091231_bib19","doi-asserted-by":"crossref","unstructured":"Madras BK, Fahey MA, Bergman J, Canfield DR, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251: 131-141.","DOI":"10.1016\/S0022-3565(25)20684-X"},{"key":"10.1124\/jpet.105.091231_bib20","doi-asserted-by":"crossref","unstructured":"Newman AH, Allen AC, Izenwasser S, and Katz JL (1994) Novel 3\u03b1-(diphenylmethoxy) tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37: 2258-2261.","DOI":"10.1021\/jm00041a002"},{"key":"10.1124\/jpet.105.091231_bib21","doi-asserted-by":"crossref","unstructured":"Newman AH, Kline RH, Allen AC, Izenwasser S, George C, and Katz JL (1995) Novel 4\u2032-substituted and 4\u2032,4\u2032-disubstituted 3\u03b1-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors. J Med Chem 38: 3933-3940.","DOI":"10.1021\/jm00020a006"},{"key":"10.1124\/jpet.105.091231_bib22","doi-asserted-by":"crossref","unstructured":"Newman AH and Kulkarni SS (2002) Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2014a focus on analogues of benztropine and rimcazole. Med Res Rev 22: 1-36.","DOI":"10.1002\/med.10014"},{"key":"10.1124\/jpet.105.091231_bib23","doi-asserted-by":"crossref","unstructured":"P\u00f6g\u00fcn S, Scheffel U, and Kuhar MJ (1991) Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur J Pharmacol 198: 203-205.","DOI":"10.1016\/0014-2999(91)90622-W"},{"key":"10.1124\/jpet.105.091231_bib24","doi-asserted-by":"crossref","unstructured":"Raje S, Cao J, Newman AH, Gao H, and Eddington ND (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307: 801-808.","DOI":"10.1124\/jpet.103.053504"},{"key":"10.1124\/jpet.105.091231_bib25","doi-asserted-by":"crossref","unstructured":"Reith ME (1988) Cocaine receptors on monoamine transporters and sodium channels. NIDA Res Monogr 88: 23-43.","DOI":"10.1037\/e496572006-003"},{"key":"10.1124\/jpet.105.091231_bib26","doi-asserted-by":"crossref","unstructured":"Reith MEA, Berfield JL, Wang LC, Ferrer JV, and Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276: 29012-29018.","DOI":"10.1074\/jbc.M011785200"},{"key":"10.1124\/jpet.105.091231_bib27","doi-asserted-by":"crossref","unstructured":"Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237: 1219-1223.","DOI":"10.1126\/science.2820058"},{"key":"10.1124\/jpet.105.091231_bib28","doi-asserted-by":"crossref","unstructured":"Rothman RB, Grieg N, Kim A, De Costa BR, Rice KC, Carroll FI, and Pert A (1992) Cocaine and GBR 12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacol Biochem Behav 43: 1135-1142.","DOI":"10.1016\/0091-3057(92)90493-Y"},{"key":"10.1124\/jpet.105.091231_bib29","doi-asserted-by":"crossref","unstructured":"Scheffel U, Dannals RF, Wong DF, Yokoi F, Carroll FI, and Kuhar MJ (1992) Dopamine transporter imaging with novel, selective cocaine analogs. Neuroreport 3: 969-972.","DOI":"10.1097\/00001756-199211000-00005"},{"key":"10.1124\/jpet.105.091231_bib30","doi-asserted-by":"crossref","unstructured":"Scheffel U, P\u00f6g\u00fcn S, Stathis M, Boja JW, and Kuhar MJ (1991) In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. J Pharmacol Exp Ther 257: 954-958.","DOI":"10.1016\/S0022-3565(25)24798-X"},{"key":"10.1124\/jpet.105.091231_bib31","unstructured":"Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed, Iowa State University Press, Ames, Iowa."},{"key":"10.1124\/jpet.105.091231_bib32","doi-asserted-by":"crossref","unstructured":"Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, and Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119: 376-384.","DOI":"10.1007\/BF02245852"},{"key":"10.1124\/jpet.105.091231_bib33","doi-asserted-by":"crossref","unstructured":"Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K Jr, and Berger SP (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289: 110-122.","DOI":"10.1016\/S0022-3565(24)38113-3"},{"key":"10.1124\/jpet.105.091231_bib34","doi-asserted-by":"crossref","unstructured":"Vaugeois JM, Bonnet JJ, Duterte-Boucher D, and Costentin J (1993) In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Eur J Pharmacol 230: 195-201.","DOI":"10.1016\/0014-2999(93)90802-O"},{"key":"10.1124\/jpet.105.091231_bib35","doi-asserted-by":"crossref","unstructured":"Vaughan RA, Agoston GE, Lever JR, and Newman AH (1999) Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. J Neurosci 19: 630-636.","DOI":"10.1523\/JNEUROSCI.19-02-00630.1999"},{"key":"10.1124\/jpet.105.091231_bib36","doi-asserted-by":"crossref","unstructured":"Volkow ND, Fowler JS, and Wang GJ (2002) Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13: 355-366.","DOI":"10.1097\/00008877-200209000-00008"},{"key":"10.1124\/jpet.105.091231_bib37","doi-asserted-by":"crossref","unstructured":"Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D, Franceschi M, Logan J, Gatley SJ, Wong C, et al. (2000) Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci 67: 1507-1515.","DOI":"10.1016\/S0024-3205(00)00731-1"},{"key":"10.1124\/jpet.105.091231_bib38","doi-asserted-by":"crossref","unstructured":"Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (Lond) 386: 827-830.","DOI":"10.1038\/386827a0"},{"key":"10.1124\/jpet.105.091231_bib39","doi-asserted-by":"crossref","unstructured":"Woolverton WL, Hecht GS, Agoston GE, Katz JL, and Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154: 375-382.","DOI":"10.1007\/s002130000616"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524322669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524322669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.091231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:36:10Z","timestamp":1740000970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524322669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0022356524322669"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.091231","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between in Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine Analogs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.091231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}